Abstract Background Seroprevalence of IgG antibodies against SARS-CoV-2 is an important
tool to estimate the true extent of infection in a population. However, seroprevalence studies …

Background Prevalence of IgG antibodies against SARS-CoV-2 infection provides essential
information for deciding disease prevention and mitigation measures. We estimate the …

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has had a massive
impact on public health as well as the economy. Understanding the seroprevalence of …

Background Many studies examined the spread of SARS-CoV-2 within populations using
seroprevalence. Healthcare workers are a high-risk population due to patient contact, and …

Objectives We designed a population-based survey in Kashmir to estimate the
seroprevalence of SARS-CoV-2-specific IgG antibodies in the general population aged 18 …

Objectives Healthcare workers (HCWs) are at a high risk of contracting severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) due to the increased likelihood of clinical …

Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Background India began COVID-19 vaccination in January 2021, initially targeting
healthcare and frontline workers. The vaccination strategy was expanded in a phased …

Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence
of 17.1% among the general population in the first wave of the epidemic by April, 2020. The …

Objectives To study the percentage seropositivity for SARS-CoV-2 to understand the
pandemic status and predict the future situations in Ahmedabad. Study design Cross …